Structure Therapeutics Inc. American Depositary Shares Earnings Dividend

Structure Therapeutics Inc. American Depositary Shares’s revenue jumped NaN% since last year same period to $0Mn in the Q1 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated NaN% jump in its revenue since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s net profit fell -62.69% since last year same period to $-76.19Mn in the Q1 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated -330.86% fall in its net profits since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s net profit margin jumped NaN% since last year same period to -Inf% in the Q1 2026. On a quarterly growth basis, Structure Therapeutics Inc. American Depositary Shares has generated NaN% jump in its net profit margins since last 3-months.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) estimates for the current quarter stand at -0.35 - a -25% fall from last quarter’s estimates.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) estimates for the current year stand at -0.35.

Structure Therapeutics Inc. American Depositary Shares’s earning per share (EPS) jumped 57.32% since last year same period to -0.35 in the Q1 2026. This indicates that the Structure Therapeutics Inc. American Depositary Shares has generated 57.32% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Structure Therapeutics Inc. American Depositary Shares’s return on assets (ROA) stands at -0.12.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Structure Therapeutics Inc. American Depositary Shares’s return on equity (ROE) stands at -0.15.